Biobank-based research on digestive peritoneal carcinomatosis (the BIG-RENAPE Biobank)

https://doi.org/10.4081/joper.2016.12

Authors

  • Laurent Villeneuve | laurent.villeneuve@chu-lyon.fr Unit of Clinical Research, Department of General and Digestive Surgery, Hospital of Lyon Sud, Lyon, France. http://orcid.org/0000-0002-8713-7821
  • Peggy Jourdan-Enfer Unit of Clinical Research, Department of General and Digestive Surgery, Hospital of Lyon Sud, Lyon, France.
  • Frédéric Bibeau Department of Pathology, Val d’Aurelle Montpellier Cancer Centre, Montpellier, France.
  • Nicole Fabien Department of Immunology, Unit of Autoimmunity, Hospital of Lyon Sud, Lyon; Biologic Research Centre, Hospital of Lyon Sud, Lyon, France.
  • Elisabeth Blasco Department of Immunology, Unit of Autoimmunity, Hospital of Lyon Sud, Lyon; Biologic Research Centre, Hospital of Lyon Sud, Lyon, France.
  • Alexandra Traverse-Glehen Biologic Research Centre, Hospital of Lyon Sud, Lyon; 5Department of Pathology, Hospital of Lyon Sud, Lyon, France.
  • Olivier Glehen Unit of Clinical Research, Department of General and Digestive Surgery, Hospital of Lyon Sud, Lyon, France.

Abstract

Access to good quality biological samples is a prerequisite for highlevel translational research. The BIG-RENAPE Biobank has been established by the French hyperthermic intraperitoneal chemotherapy centers involved in the management of peritoneal surface malignancies. The Biobank is a core facility aiming to support researchers who conduct studies with sample collections, both within and outside the Big- RENAPE Network. The Biobank is certified according to NFS 96-900 and has been launched in February 2016 as a service of processing, storage and transfer of high quality biological (plasma, serum, buffy coat) and tissue (formalin-fixed-paraffin-embedded) samples from patients with digestive peritoneal carcinomatosis. Biospecimens are collected at each stage of diagnostic and therapeutic care. The patient and his derivates are anonymized and registered in a web database reporting disease status, treatments, surgical procedures, pathological diagnosis, quality of life’s assessment and long term follow-up. All participants have given their informed consent before any sample. The Biobank was approved by the local Ethical Committee, based on the assessed compliance to French regulatory rules. The Biobank is located in the Centre Hospitalier Lyon (SudBioTech), which is known to be an expert center in the management of the peritoneal carcinomatosis. Research projects that require material stored in the Biobank are submitted by specific form and evaluated by the BIG-RENAPE Scientific Committee. A material transfer agreement is agreed with the recipient before samples are allowed to be sent from the Biobank.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.
Published
2016-06-14
Info
Issue
Section
Special Articles
Keywords:
Biobanking, tissue banking., biospecimen research, prospective clinical database, tissue banking
Statistics
  • Abstract views: 826

  • PDF: 311
How to Cite
1.
Villeneuve L, Jourdan-Enfer P, Bibeau F, Fabien N, Blasco E, Traverse-Glehen A, Glehen O. Biobank-based research on digestive peritoneal carcinomatosis (the BIG-RENAPE Biobank). J Peritoneum [Internet]. 2016Jun.14 [cited 2020Sep.22];1(1). Available from: http://www.jperitoneum.org/index.php/joper/article/view/12